These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23167307)

  • 1. Efficacy of cetuximab in the treatment of squamous cell carcinoma.
    Preneau S; Rio E; Brocard A; Peuvrel L; Nguyen JM; Quéreux G; Dreno B
    J Dermatolog Treat; 2014 Oct; 25(5):424-7. PubMed ID: 23167307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Tolerance of Cetuximab Alone or Combined with Chemotherapy in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: An Open Study of 14 Patients.
    Dereure O; Missan H; Girard C; Costes V; Guillot B
    Dermatology; 2016; 232(6):721-730. PubMed ID: 28384639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetuximab-radiotherapy combination in the management of locally advanced cutaneous squamous cell carcinoma.
    Joseph K; Alkaabi K; Warkentin H; Ghosh S; Jha N; Smylie M; Walker J
    J Med Imaging Radiat Oncol; 2019 Apr; 63(2):257-263. PubMed ID: 30549229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma.
    Lavaud J; Blom A; Longvert C; Fort M; Funck-Brentano E; Saiag P
    Eur J Dermatol; 2019 Dec; 29(6):636-640. PubMed ID: 31903954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report.
    Falivene S; Giugliano FM; Grimaldi AM; Di Franco R; Toledo D; Muto M; Cammarota F; Borzillo V; Ascierto PA; Muto P
    BMC Dermatol; 2014 Sep; 14():15. PubMed ID: 25270710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab.
    Stevenson ML; Wang CQ; Abikhair M; Roudiani N; Felsen D; Krueger JG; Pavlick AC; Carucci JA
    JAMA Dermatol; 2017 Apr; 153(4):299-303. PubMed ID: 28259107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab.
    Picard A; Pedeutour F; Peyrade F; Saudes L; Duranton-Tanneur V; Chamorey E; Cardot-Leccia N; Sudaka A; Ettaiche M; Benchetrit M; Poissonnet G; Weinbreck N; Dadone B; Lacour JP; Passeron T; Montaudié H
    JAMA Dermatol; 2017 Apr; 153(4):291-298. PubMed ID: 28259104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced cutaneous squamous cell carcinomas with epidermal growth factor receptor inhibitors.
    Alter M; Satzger I; Mattern A; Kapp A; Gutzmer R
    Dermatology; 2013; 227(4):289-94. PubMed ID: 24217470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of unresectable squamous cell carcinoma of the skin with epidermal growth factor receptor antibodies--a case series.
    Eder J; Simonitsch-Klupp I; Trautinger F
    Eur J Dermatol; 2013; 23(5):658-62. PubMed ID: 24135559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients.
    Chapalain M; Baroudjian B; Dupont A; Lhote R; Lambert J; Bagot M; Lebbe C; Basset-Seguin N
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1202-1209. PubMed ID: 31587382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature.
    Jarkowski A; Hare R; Loud P; Skitzki JJ; Kane JM; May KS; Zeitouni NC; Nestico J; Vona KL; Groman A; Khushalani NI
    Am J Clin Oncol; 2016 Dec; 39(6):545-548. PubMed ID: 24879468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxel.
    Mecca C; Ponzetti A; Caliendo V; Ciuffreda L; Lista P
    Eur J Dermatol; 2012; 22(6):758-61. PubMed ID: 23131415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab.
    Kamaria M; Shea CR; Chin RK; Cohen EE; Maggiore R; Bolotin D
    Clin Exp Dermatol; 2014 Jul; 39(5):604-7. PubMed ID: 24758726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin.
    Maubec E; Petrow P; Scheer-Senyarich I; Duvillard P; Lacroix L; Gelly J; Certain A; Duval X; Crickx B; Buffard V; Basset-Seguin N; Saez P; Duval-Modeste AB; Adamski H; Mansard S; Grange F; Dompmartin A; Faivre S; Mentré F; Avril MF
    J Clin Oncol; 2011 Sep; 29(25):3419-26. PubMed ID: 21810686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma--a report of eight cases.
    Giacchero D; Barrière J; Benezery K; Guillot B; Dutriaux C; Mortier L; Lacour JP; Thyss A; Peyrade F
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):716-8. PubMed ID: 21831617
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of neoadjuvant cetuximab alone or with platinum salt for the treatment of unresectable advanced nonmetastatic cutaneous squamous cell carcinomas.
    Reigneau M; Robert C; Routier E; Mamelle G; Moya-Plana A; Tomasic G; Mateus C
    Br J Dermatol; 2015 Aug; 173(2):527-34. PubMed ID: 25704233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful combination therapy of a locally advanced squamous cell carcinoma of the skin with cetuximab and γ-irradiation.
    Göppner D; Nekwasil S; Franke I; Gollnick H; Leverkus M
    J Dtsch Dermatol Ges; 2010 Oct; 8(10):826-8. PubMed ID: 20731754
    [No Abstract]   [Full Text] [Related]  

  • 19. Cetuximab as a Component of Multimodality Treatment of High-Risk Cutaneous Squamous Cell Carcinoma: A Retrospective Analysis From a Single Tertiary Academic Medical Center.
    Trodello C; Higgins S; Ahadiat O; Ragab O; In G; Hawkins M; Wysong A
    Dermatol Surg; 2019 Feb; 45(2):254-267. PubMed ID: 30672860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.